2003
DOI: 10.1016/s0022-2836(03)00023-8
|View full text |Cite
|
Sign up to set email alerts
|

Solution Structure of the Chick TGFβ Type II Receptor Ligand-binding Domain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2005
2005
2018
2018

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 38 publications
0
8
0
Order By: Relevance
“…The four that have been characterized structurally thus far, ActRIIa, 23 ActRIIb, 21,24 TbRII, [25][26][27] and BMPRIa, 19 have been shown to adopt a three finger toxin fold and to share four structurally conserved disulfide bonds. TbRI-ED, which has a predicted extracellular domain 101 residues in length, 11 is expected to adopt a similar structure as its ten cysteine residues are positionally conserved relative to those in BMPRIa ( Figure 1).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The four that have been characterized structurally thus far, ActRIIa, 23 ActRIIb, 21,24 TbRII, [25][26][27] and BMPRIa, 19 have been shown to adopt a three finger toxin fold and to share four structurally conserved disulfide bonds. TbRI-ED, which has a predicted extracellular domain 101 residues in length, 11 is expected to adopt a similar structure as its ten cysteine residues are positionally conserved relative to those in BMPRIa ( Figure 1).…”
Section: Resultsmentioning
confidence: 99%
“…BMPRIa-ED 28,29 and ActRIIb-ED 21 were expressed as thioredoxin fusions that remained soluble and yielded active protein upon purification. TbRII-ED has been expressed both fused to thioredoxin 25 and alone. 30,31 The fusion protein remained soluble and yielded active protein, 25 while TbRII-ED expressed alone was insoluble but could be refolded to yield active protein.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…25 kDa) and receptor ectodomains (11 – 16 kDa) has enabled studies of both using NMR [20,55,57,58,64,79,105107] and X-ray crystallography [19,21,22,96,98,102,108110]. The strategies used to obtain the NMR solution structures and X-ray crystal structures of the signaling proteins and receptor ectodomains more or less follow the standard methodologies.…”
Section: Methodsmentioning
confidence: 99%
“…Our attempts to follow reported protocols for folding TBRIII-ECD from inclusion bodies [11,12,31] afforded highly variable yields of active protein; often less than 1 mg of protein was recovered from 50 mg of solubilized inclusion bodies. Although a thioredoxin fusion enhanced the solubility of chicken Trx-TBRII-ECD [32,33], production of the corresponding human Trx-TBRII-ECD fusion resulted in soluble but nonfunctional protein that failed to bind TGF-β1. A protocol for folding Trx-TBRII-ECD on Ni–NTA agarose was previously reported [13]; however, it employs a high concentration of arginine at pH 8.0, which interferes with protein binding to Ni–NTA agarose [34].…”
Section: Resultsmentioning
confidence: 99%